Regenxbio (RGNX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

RGNX Regenxbio

Watchlist

7.620
+0.210+2.83%

Close Dec 20 16:00 ET

7.710
+0.090+1.18%

Post 20:01 ET

377.53MMarket Cap-1.52P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

PepGen Stock Craters 35% on FDA Clinical Hold
Seeking AlphaDec 16 09:56 ET
RBC Capital Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $35
Moomoo NewsDec 11 07:33 ET · Ratings
RBC Capital Sticks to Its Buy Rating for RegenXBio (RGNX)
TipRanksDec 11 06:39 ET · Ratings
Express News | Regenxbio Inc - to Offer and Sell Shares up to $150 Million
ReutersDec 9 16:48 ET
Express News | Regenxbio Inc - on Dec 9, Co Enters Sales Agreement With Leerink Partners
ReutersDec 9 16:48 ET
Apollo Global Management, Workday to Join S&P 500
MT NewswiresDec 9 06:31 ET

Comments

Stock_Drift

Oct 21 06:09

$Regenxbio (RGNX.US)$

Stock_Drift

Sep 23 15:16

$Regenxbio (RGNX.US)$

Bingrru

Aug 1 09:20

$Regenxbio (RGNX.US)$

Tao Lao Zoa

Mar 5 11:19

$Regenxbio (RGNX.US)$ SELL SELL SELL NOW EASY MONEY AND ENJOIN YOURS TAKE BREAK TOMORROW 💰💰💰😋😋😋🤩🤩🤩

Moomoo AI

Feb 17 07:06

Investors' pessimism about the company's revenue prospects may be causing the low P/S ratio. The company's forecast growth is lower than the wider industry, which could be contributing to the depressed P/S. It's hard to see the share price rising strongly in the near future given these circumstances.

There's No Escaping REGENXBIO Inc.'s (NASDAQ:RGNX) Muted Revenues Despite A 33% Share Price Rise

Heat List

Overall

No Data